Form D · Retailing
MandaraRx. Inc.
Boulder, CO · CIK 0001838106
Offering snapshot reported Jan 12, 2021 · SEC filing
- Reported sold
- $2.04M Offering amount: $3.04M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jun 6, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2021 | Initial | $2,035,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-385968
Source: Form D, filed Jan 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Hurley | Director, Executive |
| Wallace Reams | Director, Executive |
| Brett Robert Sweezy | Director, Executive |
Issuer details
Industry: Retailing (See others in industry)
Address:
Kiln Boulder, Attn. Mandara 2101 Pearl St.
Boulder, CO, 80302
Boulder, CO, 80302